This finding was consistent with reports that underlined a strong link between UBE2C overexpression and the degree of tumour differentiation in many cancers (breast, lung, ovary, bladder, and glioblastomas) (Okamoto et al, 2003; Wagner et al, 2004). Here, UBE2C is linked to cancer.